Bio-Rad Laboratories, Inc.
NYSE · Technology · Laboratory Analytical Instruments · Hercules, CA
BIO-B chart
What traders are saying about $BIO-B
Latest postsBio-Rad Laboratories, Inc. news
- BIO (BIO) vs. TMO and DHR: Can Activist Pressure Close Bio-Rad’s Valuation Discount?
Yahoo Finance ·
- Zebra's revenue and earnings beat expectations; Leslie's Inc. withdraws outlook amid liquidity concerns.
Pluang ·
- Ariel Fund Q3 2026 Commentary (Mutual Fund:ARGFX)
Seeking Alpha ·
- Missed Out On Bio Rad Laboratories' Run? Here Is The Bet Holders Made
Simply Wall Street ·
- Bio-rad Laboratories Stock Price Forecast. Should You Buy BIO?
StockInvest.us ·
- Form 4 BIO-RAD LABORATORIES: Sedat Evran (EVP, Global Supply Chain) For: 20 October
Investing.com Nigeria ·
- Sedat Evran Reports Vesting of 1,044 Bio-Rad RSUs with Tax Share Disposal on October 20, 2026
Kalkine Media ·
- Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts
Yahoo Finance ·
- Avoiding Lag: Real-Time Signals in (BIO) Movement
Stock Traders Daily ·
- Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026
Yahoo Finance ·
- Cell Isolation / Cell Separation - Global Strategic Business Report: Secure Share of a US$42.8 Billion Market by 2030 as BD Biosciences, Beckman Coulter, Bio-Rad and Thermo Fisher Accelerate
Yahoo Finance ·
- Global Cell-Based Assays Market Report 2026-2030 | Secure Share in the $54.79 Billion Market Growing at 13.3% as Promega, Bio-Rad, PerkinElmer, and Danaher Scale AI Automation
Yahoo Finance ·
Bio-Rad Laboratories, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.58B | $2.57B | $2.67B | $2.80B |
| Net income | $759.9M | -$1.84B | -$637.3M | -$3.63B |
| Diluted EPS | $27.85 | $-65.36 | $-21.82 | $-121.79 |
| Total assets (year end) | $10.58B | $9.36B | $12.30B | $13.50B |
| Cash and equivalents (year end) | $529.8M | $488.1M | $403.8M | $434.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Bio-Rad Laboratories, Inc.
- Ticker
- BIO-B (NYSE)
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Hercules, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 12208
- Former names
- BIO RAD LABORATORIES INC
Frequently asked questions
What exchange is Bio-Rad Laboratories, Inc. listed on?
Bio-Rad Laboratories, Inc. trades on the NYSE under the ticker symbol BIO-B.
What industry is Bio-Rad Laboratories, Inc. in?
Bio-Rad Laboratories, Inc. is classified by the SEC under "Laboratory Analytical Instruments", part of the Technology sector on StockTweeting.
Where is Bio-Rad Laboratories, Inc. headquartered?
Bio-Rad Laboratories, Inc.'s business address on file with the SEC is in Hercules, CA.
When does Bio-Rad Laboratories, Inc.'s fiscal year end?
Bio-Rad Laboratories, Inc.'s fiscal year ends on December 31.
How much revenue did Bio-Rad Laboratories, Inc. report?
Bio-Rad Laboratories, Inc. reported $2.58B in revenue for calendar year 2025, according to its SEC filings.